Atul Deodhar, MD, MRCP, from Oregon Health and Science University, answers our questions about the findings from the DISCOVER-1 clinical trial on the efficacy of guselkumab for the treatment of patients...
Jillian Rose, PhD, MPH, LCSW, and Priscilla Toral, LCSW, both from Hospital for Special Surgery, answer our questions about their research on self-reported needs and concerns of men with systemic lupus...
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem,...
A new study team evaluated whether midlife obesity is a cause of dementia and whether risk factors such as diet or physical inactivity were causes or consequences of the gradual onset of dementia. Lead...
Manal Abdelmalek, MD, MPH, from Duke University, answers our questions about the challenges in the diagnosis and staging of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
David Bursill, MD, answers our questions about the consensus statement from the Gout, Hyperuricemia and Crystal-Associated Disease Network on recommended nomenclature for disease states of gout.
Diego J. Maselli, MD, answers our questions about choosing the right biologic for patients with severe asthma, the costs of biologics, and challenges to patient adherence to these therapies.
Lorenzo Subissi, PhD, answers our questions about his study that investigated subsequent mortality among people discharged from a treatment center after the 2013-2016 Ebola outbreak in West Africa.
Nutrition411 spoke with Jo Ann Carson, PhD, RDN, about the American Heart Association’s latest science advisory on dietary cholesterol and cardiovascular risk, which was published in Circulation. February...
Researchers evaluated improvements in predicting 5-year AF risk when adding novel candidate variables identified by machine learning to the CHARGE-AF Enriched score. Lead researcher Joshua Bundy, PhD, MPH,...
